Evidence map›Paper›PMID 34060328›Full record

ArticlemBio2021

Challenges and Controversies Concerning Neisseria gonorrhoeae-Neutrophil Interactions in Pathogenesis.

Alison K Criss, Caroline A Genco, Scott D Gray-Owen, Ann E Jerse, H Steven Seifert

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Alison K Criss *University of Virginia School of Medicine, University of Virginia, Global Infectious Diseases Institute, Charlottesville, Virginia, USA.
Caroline A Genco *Tufts University School of Medicine, Boston, Massachusetts, USA.
Scott D Gray-Owen *Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Ann E Jerse *Uniformed Services University, Bethesda, Maryland, USA.
H Steven Seifert *Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Northwestern University · USTufts University · USUniformed Services University of the Health Sciences · USUniversity of Toronto · CAUniversity of Virginia · US

Funding

The Gonorrhea Vaccine Cooperative Research CenterU19AI144180 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI SIKORA, ALEKSANDRA ELZBIETA · 2019 to 2023
$10.7M
Mechanisms of Gonococcal Pilin Antigenic/Phase VariationR37AI033493 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Hank S. SEIFERT · 2003 to 2026
$10.1M
Using gonococcal TonB-dependent transporters as vaccine antigensU19AI144182 · NIAID · GEORGIA STATE UNIVERSITY · PI SEIB, KATE LOUISE · 2019 to 2023
$9.3M
Neisseria gonorrhoeae metal transporters that subvert nutritional immunityR01AI127793 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CYNTHIA N CORNELISSEN, Alison K Criss · 2017 to 2026
$6.8M
Gonococcal Vaccine Evaluation in a Humanized Mouse ModelR01AI103400 · NIAID · BOSTON MEDICAL CENTER · PI WETZLER, LEE MARK · 2013 to 2020
$5.2M
Survival of Neisseria gonorrhoeae after primary human neutrophil challengeR01AI097312 · NIAID · UNIVERSITY OF VIRGINIA · PI CRISS, ALISON K · 2012 to 2022
$4.6M
Targeting the functions of the gonococcal Type lV pilusR01AI146073 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Hank S. SEIFERT · 2020 to 2026
$3.3M
Microbial Disruption of Dendritic Cell Maturation and FunctionR01AI142628 · NIAID · TUFTS UNIVERSITY BOSTON · PI GENCO, CAROLINE A · 2018 to 2022
$3.0M
Global Transcriptome Analysis of Mucosal Gonoccal InfectionR01AI116969 · NIAID · TUFTS UNIVERSITY BOSTON · PI GENCO, CAROLINE A · 2016 to 2019
$2.7M
The Gonococcal Fur Regulon Link to PathogenesisR01AI130946 · NIAID · TUFTS UNIVERSITY BOSTON · PI GENCO, CAROLINE A · 2017 to 2020
$2.0M
Survival of Neisseria gonorrhoeae after primary human neutrophil challengeR37AI097312 · NIAID · UNIVERSITY OF VIRGINIA · PI Alison K Criss · 2025 to 2026
$1.1M
An unbiased screen to identify Neisseria gonorrhoeae genes important for survival to neutrophil killing mechanismsR21AI148981 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SEIFERT, HANK S. · 2020 to 2021
$437k
CIHR PJT-153177NIAID NIH HHS R01 AI097312NIAID NIH HHS R01 AI103400NIAID NIH HHS R01 AI116969NIAID NIH HHS R01 AI127793NIAID NIH HHS R01 AI130946NIAID NIH HHS R01 AI142628NIAID NIH HHS R01 AI146073NIAID NIH HHS R21 AI148981NIAID NIH HHS R21 AI157539NIAID NIH HHS R37 AI033493NIAID NIH HHS R37 AI097312NIAID NIH HHS U19 AI144180NIAID NIH HHS U19 AI144182
6 · The paper itself

Abstract

The bacterium Neisseria gonorrhoeae (Ngo) is the main cause of the sexually transmitted infection gonorrhea. The global incidence of 87 million new Ngo infections each year, rising infection rates, and the emergence of Ngo strains that are resistant to all clinically recommended antibiotics have raised the specter of untreatable infections (M. Unemo, H. S. Seifert, E. W. Hook, III, S. Hawkes, et al., Nat Rev Dis Primers 5:79, 2019, https://doi.org/10.1038/s41572-019-0128-6). Given their abundance in symptomatic disease, neutrophils are central to both Ngo infection and consequent damage to host tissues. This article highlights present knowledge and the main open questions about Ngo-neutrophil interactions in immunity versus disease pathogenesis.

Indexed as

GonorrheaHumansNeisseria gonorrhoeaeNeutrophilsgonorrheaNeisseria gonorrhoeaeneutrophils

Identifiers

PMID34060328
PMCPMC8262874
OpenAlexW3164676328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.